AbbVie
ABBV
#25
Rank
A$745.81 B
Marketcap
A$421.93
Share price
1.07%
Change (1 day)
25.36%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): A$12.75 Billion

According to AbbVie's latest financial reports the company's current earnings are A$64.38 Billion. In 2025 the company made an earning of A$9.55 Billion, an increase over its 2024 earnings that were of A$5.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$12.75 B33.47%
2025 A$9.55 B77.53%
2024 A$5.38 B-40.54%
2023 A$9.05 B-53.62%
2022 A$19.52 B3.76%
2021 A$18.81 B282.25%
2020 A$4.92 B-59.67%
2019 A$12.20 B62.13%
2018 A$7.52 B-32.74%
2017 A$11.19 B-1.99%
2016 A$11.41 B18.65%
2015 A$9.62 B180.5%
2014 A$3.43 B-55.57%
2013 A$7.72 B-6.86%
2012 A$8.29 B56.05%
2011 A$5.31 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.00 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.35 B 299.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.89 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.46 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.84 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.41 B 30.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.75 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$10.36 B-17.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.18 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA